Key result
Vitamin K reversal cuts annual warfarin-associated hip fracture care costs ~75% vs. temporary cessation.
Answers are grounded in this paper and cite their sources.
BACKGROUND: Hip fractures require operation within 36-48 h, and they are most common in the elderly. A high International Normalized Ratio should be corrected before surgery. In the current study, we analyzed the budget impact of various warfarin reversal approaches. METHODS: Four reversal strategies were chosen for the budget impact analysis: the temporary withholding of warfarin, administration of vitamin K, fresh frozen plasma (FFP), and a four-factor prothrombin complex concentrate (PCC). RESULTS: We estimated that, annually, 410 hip fracture patients potentially require warfarin reversal in Finland. The least costly treatment was vitamin K, which accounted for €289,000 in direct healthcare costs, and the most costly treatment option was warfarin cessation, which accounted for €1,157,000. In the budget impact analysis, vitamin K, PCC and FFP would be cost-saving to healthcare compared with the current treatment mix. CONCLUSION: The various warfarin reversal strategies have different onset times, which may substantially impact the subsequent healthcare costs.
No takes yet. Share an insight, caveat, or question.
Purmonen et al. (2015) studied Hip fracture requiring warfarin reversal (n=410). Vitamin K, four-factor prothrombin complex concentrate (PCC), or fresh frozen plasma (FFP) vs. Temporary withholding of warfarin and current treatment mix was evaluated on Annual direct healthcare costs and budget impact. Vitamin K was the least costly warfarin reversal strategy for hip fracture patients at €289,000 annually, compared with €1,157,000 for temporary warfarin cessation.
Synapse has enriched 10 related papers. Consider them for comparative context: